Watch PRI’s Dr. Wayne Winegarden, director of the Center for Medical Economics and Innovation, discuss how the drug price control provisions in the so-called Inflation Reduction Act will impact innovation in an interview on ...
29 July, 2022
DOWNLOAD THE BRIEF Cultivating an efficient health insurance market requires reforms that empower patients over payers, which can be achieved by: Making health expenditures and health insurance expenditures tax deductible; ...
26 July, 2022
In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient cost...
07 July, 2022
DOWNLOAD THE BRIEF Cultivating an efficient health insurance market requires reforms that empower patients over payers, which can be achieved by: Making health expenditures and health insurance expenditures tax deductible; ...
26 July, 2022DOWNLOAD THE STUDY As the federal government and states such as California consider taxing and imposing new or stricter regulations on vaping products, particularly flavored products, Roger Bate, Ph.D. finds that there are ...
21 June, 2022
America’s broken third-party healthcare payment system prioritizes government and insurance companies as the largest payers, leaving patients with higher out-of-pocket costs, greater exposure to healthcare financial risk, and redu...
28 April, 2022
Watch PRI’s Dr. Wayne Winegarden, director of the Center for Medical Economics and Innovation, discuss how the drug price control provisions in the so-called Inflation Reduction Act will impact innovation in an interview on ...
29 July, 2022
In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient cost...
07 July, 2022Watch PRI’s Wayne Winegarden, director of our Center for Medical Economics and Innovation, discuss efforts by the Federal Trade Commission to considering ordering large pharmacy benefits managers to study the competitive imp...
18 February, 2022
Watch PRI’s Dr. Wayne Winegarden, director of the Center for Medical Economics and Innovation, discuss how the drug price control provisions in the so-called Inflation Reduction Act will impact innovation in an interview on ...
29 July, 2022
DOWNLOAD THE BRIEF Cultivating an efficient health insurance market requires reforms that empower patients over payers, which can be achieved by: Making health expenditures and health insurance expenditures tax deductible; ...
26 July, 2022
In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient cost...
07 July, 2022
Commentary
VA issues illustrate pitfalls of government health care
In the fall of 2020, a patient in Augusta, Georgia, went to the local Veterans Affairs medical center for a minimally invasive urologic surgery, according to a new report from the VA’s Office of Inspector General. Less than two we...
15 August, 2022Medicare for All Wouldn’t Have Saved Us From COVID
Could Medicare for All have averted more than 330,000 deaths over the course of the COVID-19 pandemic? That’s the claim of a new study published by 10 researchers from four different universities in Proceedings of the Nation...
13 August, 2022Dems’ Reconciliation Package Obscures Obamacare’s Failures With Taxpayer Cash
With fewer than 100 days until the midterms and President Biden’s approval rating underwater, Democrats are desperate for a political win they can trumpet on the campaign trail. They’re hoping the deceptively named Inf...
12 August, 2022